Clinical Endpoints

Clinical Endpoints
Relieving the Safety Reporting Burden on Sites: 4 Takeaways
Articles
Clinical Endpoints
See How WCG Helped a Mid-tier Biopharma Respond to an Urgent FDA Request, and Adjudicated 400 Endpoints in Just a Few Short Weeks
Case Studies
Clinical Endpoints
New Scale for Measuring Non-Motor Fluctuations in Parkinson’s Disease
Blog Posts
Clinical Endpoints
The Burden of Safety Reporting on Sites: An Oncology Site’s Perspective
Videos
Clinical Endpoints
Developing Psychedelics for Use in CNS Disorders
Blog Posts
Clinical Endpoints
Regulatory Challenges in Pediatric Drug Development: The European Perspective
Blog Posts
Clinical Endpoints
Using eCOA to Improve Data Quality in Parkinson’s Disease Clinical Trials
Blog Posts
Clinical Endpoints
How WCG Statistics Collaborative Helped Breakthrough Therapy Obtain Regulatory Approval
Case Studies
Clinical Endpoints
How a Top 25 Pharma Company Reduced the Placebo Response for their Phase II Study
Case Studies
Clinical Endpoints